Genetic diagnostic profiling in axial spondyloarthritis: a real world study
Gethin Thomas(The University of Queensland), Brown, Philip C. Robinson(The University of Queensland), J. Braun, Martín Rudwaleit(Bielefeld University), Rafael Valle‐Oñate(Hospital Militar Central), Nurullah Akkoç(Izmir Institute of Technology), Paul Leo(The University of Queensland), James Cheng‐Chung Wei(China Medical University), J. Sieper(Charité - Universitätsmedizin Berlin), Adrián Cortés(Institut thématique Génétique, génomique et bioinformatique), Dana Willner(The University of Queensland), Walter P. Maksymowych(University of Alberta), Euthalia Roussou(Barking, Havering And Redbridge University Hospitals NHS Trust), Ran Duan(Central South University), Désirée van der Heijde(Leiden University Medical Center), Salih Özgöçmen(Tokat Gaziosmanpaşa Üniversitesi), Chien‐Wen Chou(China Medical University)
Data Archiving and Networked Services (DANS)
January 1, 2016
Cited by 0
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k